Krakowski Szpital Specjalityczny im. Jana Pawla II

Krakow 31-202

0 studies enrolling now · 1 studies all time

What they study most

Advanced or Metastatic Non-small Cell Lung Cancer

Studies at this site

• A Study of Lazertinib With Subcutaneous Amivantamab Compared With Intravenous Amivantamab in Participants With Epidermal Growth Factor Receptor (EGFR)-Mutated Advanced or Metastatic Non-small Cell Lung Cancer — Running, not enrolling